MRVI Stock Predictions
| Recent MRVI Stock Price | MRVI Stock Predictions | |
| $8.80 |  +15.34% |
$10.15 |
| Recent MRVI Analyst Ratings Breakdown, Making MRVI Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 7 | 6 | 6 | 6 |
| Buy ratings: | 2 | 2 | 2 | 2 |
| Hold ratings: | 3 | 3 | 3 | 3 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.63 | 1.68 | 1.68 | 1.68 |
For the MRVI stock predictions from the analysts covering Maravai LifeSciences Holdings Inc, we have collected all of the individual MRVI stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 10 different analysts covering MRVI (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since MRVI stock predictions may vary widely, another useful metric to consider is the median MRVI stock prediction, which represents the price at which half of the analysts
made MRVI stock predictions that were higher and half made MRVI stock predictions that were lower. This makes for a different take on the MRVI stock predictions out there, as compared to average or mean.
And that median across all the individual MRVI stock predictions was: $10.0 as of 2024-05-03.
The very highest of the MRVI stock predictions for one year price target was $15.0, while the very lowest of the MRVI stock predictions in the analyst group was
$6.5 (with a standard deviation of $2.769). Get the latest Zacks research report on MRVI — FREE
Find out: MRVI next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• PRGS Stock Predictions
• IEA Stock Predictions
• WRI Stock Predictions
• SBBP Stock Predictions
• BKNG Stock Predictions
• LEU Stock Predictions
• CLB Stock Predictions
• OESX Stock Predictions
• ARDX Stock Predictions
|
|||||||||
|
|
|
|
|
|
Free Email Alerts:
Avg. Broker Rec.
 
|
Buy (3.37 out of 4) 54th percentile
(ranked higher than approx. 54% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
